District of Columbia Statutes
§ 48-842.02 — Definitions.
District of Columbia § 48-842.02
This text of District of Columbia § 48-842.02 (Definitions.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
D.C. Code § 48-842.02 (2026).
Text
For the purposes of this chapter, the term:
(1)“Medication advisory committee” means any committee or panel that is responsible for making recommendations or decisions regarding a formulary to be used by a health program administered by the government of the District of Columbia.
(2)“Pharmaceutical company” means any entity that is engaged in, either directly or indirectly, the production, preparation, propagation, compounding, manufacturing, conversion or processing of a drug or biological product, including any person acting as its agent or representative.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
Mar. 26, 2008, D.C. Law 17-131, § 302, 55 DCR 1659
Nearby Sections
15
§ 48-1001
Definitions.§ 48-1003
Notice of a drug free zone.§ 48-1004
Prohibition.§ 48-1005
Penalties.§ 48-1006
Reporting.§ 48-102
Definitions — “Drug”; “food”.§ 48-105
Complaints to be investigated.§ 48-108.01
Administrative remedies for enforcement.Cite This Page — Counsel Stack
Bluebook (online)
District of Columbia § 48-842.02, Counsel Stack Legal Research, https://law.counselstack.com/statute/dc/48-842.02.